Login to Your Account



FDA, Salix Seek Answers on Testing Antibiotic to Treat IBS

By Mari Serebrov
Washington Editor

Tuesday, November 15, 2011
Both the FDA and Salix Pharmaceuticals Inc. will be looking to members of the Gastrointestinal Drugs Advisory Committee Wednesday for answers on designing a clinical trial to demonstrate the safety and efficacy of an antibiotic intended to be used intermittently to treat a chronic condition.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription